178 results
Page 2 of 9
8-K
EX-10.1
ungm4 4dm
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.2
c83o14sviqcz3ac7172
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
9yvj61p9h2jfblsq6e
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.2
9v9kp98o
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.2
8lqgcn
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-10.1
bn6p128 cvpk8oj4d6q
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-4.1
a0mutqv4md76v
14 Mar 19
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results
4:18pm
8-K
EX-10.1
5ce64zes5j xak7qi
14 Mar 19
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results
4:18pm